Literature DB >> 33436016

Interleukin-17 receptor D (Sef) is a multi-functional regulator of cell signaling.

Shivangi Pande1,2, Xuehui Yang1, Robert Friesel3,4.   

Abstract

Interleukin-17 receptor D (IL17RD or IL-17RD) also known as Sef (similar expression to fibroblast growth factor), is a single pass transmembrane protein that is reported to regulate several signaling pathways . IL17RD was initially described as a feedback inhibitor of fibroblast growth factor (FGF) signaling during zebrafish and frog development. It was subsequently determined to regulate other receptor tyrosine kinase signaling cascades as well as several proinflammatory signaling pathways including Interleukin-17A (IL17A), Toll-like receptors (TLR) and Interleukin-1α (IL1α) in several vertebrate species including humans. This review will provide an overview of IL17RD regulation of signaling pathways and functions with emphasis on regulation of development and pathobiological conditions. We will also discuss gaps in our knowledge about IL17RD function to provide insight into opportunities for future investigation. Video Abstract.

Entities:  

Keywords:  Cellular signaling; Fibroblast growth factor (FGF); Fibroblast growth factor receptor (FGFR); Interleukin-17; Interleukin-17 receptor D (IL17RD); Sef

Mesh:

Substances:

Year:  2021        PMID: 33436016      PMCID: PMC7805053          DOI: 10.1186/s12964-020-00695-7

Source DB:  PubMed          Journal:  Cell Commun Signal        ISSN: 1478-811X            Impact factor:   5.712


  72 in total

1.  Activation of TAK1 by Sef-S induces apoptosis in 293T cells.

Authors:  Xiaojun Sun; Yinyin Wang; Shigao Yang; Fangli Ren; Yongjing Xia; Zhijie Chang
Journal:  Cell Signal       Date:  2013-06-11       Impact factor: 4.315

Review 2.  Know thy Sef: a novel class of feedback antagonists of receptor tyrosine kinase signaling.

Authors:  Dina Ron; Yaron Fuchs; Dror S Chorev
Journal:  Int J Biochem Cell Biol       Date:  2008-03-25       Impact factor: 5.085

3.  Prevalence and associated phenotypes of DUSP6, IL17RD and SPRY4 variants in a large Chinese cohort with isolated hypogonadotropic hypogonadism.

Authors:  Meichao Men; Xinying Wang; Jiayu Wu; Wang Zeng; Fang Jiang; Ruizhi Zheng; Jia-Da Li
Journal:  J Med Genet       Date:  2020-05-10       Impact factor: 6.318

4.  Expression and regulation of the tumor suppressor, SEF, during folliculogenesis in humans and mice.

Authors:  Ela Lutwak; Christopher A Price; Sagit-Sela Abramovich; Shiri Rabinovitz; Irit Granot; Nava Dekel; Dina Ron
Journal:  Reproduction       Date:  2014-08-12       Impact factor: 3.906

5.  Sef-S, an alternative splice isoform of sef gene, inhibits NIH3T3 cell proliferation via a mitogen-activated protein kinases p42 and p44 (ERK1/2)-independent mechanism.

Authors:  Zhili Rong; Yongming Ren; Long Cheng; Zhiyong Li; Yinghua Li; Yang Sun; Hongge Li; Shiqin Xiong; Zhijie Chang
Journal:  Cell Signal       Date:  2006-06-08       Impact factor: 4.315

6.  Tumor necrosis factor receptor 2 (TNFR2)·interleukin-17 receptor D (IL-17RD) heteromerization reveals a novel mechanism for NF-κB activation.

Authors:  Shigao Yang; Yinyin Wang; Kunrong Mei; Sen Zhang; Xiaojun Sun; Fangli Ren; Sihan Liu; Zi Yang; Xinquan Wang; Zhihai Qin; Zhijie Chang
Journal:  J Biol Chem       Date:  2014-11-05       Impact factor: 5.157

7.  Characterization of the interleukin-17 isoforms and receptors in lesional psoriatic skin.

Authors:  C Johansen; P A Usher; R B Kjellerup; D Lundsgaard; L Iversen; K Kragballe
Journal:  Br J Dermatol       Date:  2008-10-21       Impact factor: 9.302

8.  hSef inhibits PC-12 cell differentiation by interfering with Ras-mitogen-activated protein kinase MAPK signaling.

Authors:  Shiqin Xiong; Qiuhui Zhao; Zhili Rong; Guanrong Huang; Yiling Huang; Peila Chen; Shuping Zhang; Li Liu; Zhijie Chang
Journal:  J Biol Chem       Date:  2003-09-04       Impact factor: 5.157

9.  Anterior shift in gene expression precedes anteriormost digit formation in amniote limbs.

Authors:  Asaka Uejima; Takanori Amano; Naoki Nomura; Miyuki Noro; Taiji Yasue; Toshihiko Shiroishi; Kunimasa Ohta; Hitoshi Yokoyama; Koji Tamura
Journal:  Dev Growth Differ       Date:  2010-01-20       Impact factor: 2.053

10.  The oxidative demethylase ALKBH3 marks hyperactive gene promoters in human cancer cells.

Authors:  Robert Liefke; Indra M Windhof-Jaidhauser; Jochen Gaedcke; Gabriela Salinas-Riester; Feizhen Wu; Michael Ghadimi; Sebastian Dango
Journal:  Genome Med       Date:  2015-06-30       Impact factor: 11.117

View more
  1 in total

Review 1.  Interleukin-17 Family Cytokines in Metabolic Disorders and Cancer.

Authors:  Eileen Victoria Meehan; Kepeng Wang
Journal:  Genes (Basel)       Date:  2022-09-13       Impact factor: 4.141

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.